It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

The use of mitomycin C with autologous limbal-conjunctival autograft t
skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

14789

The use of mitomycin C with autologous limbal-conjunctival autograft transplantation for management of recurrent pterygium



Case Series

(6066) Total Article Views


Authors: Mohamed A Fakhry

Published Date January 2011 Volume 2011:5 Pages 123 - 127
DOI: http://dx.doi.org/10.2147/OPTH.S16474

Mohamed A Fakhry
Department of Ophthalmology, Kasr El Aini Hospital, Cairo University, Cairo, Egypt

Purpose: The purpose of this study is to evaluate and compare recurrence rates upon using mitomycin C (MMC) with limbal-conjunctival autograft for treating recurrent pterygia.
Methodology: An interventional, prospective, comparative clinical study was performed in 30 eyes (26 patients) with recurrent pterygia, allocated into two groups: Group A (19 eyes) operated by pterygium excision and limbal-conjunctival autograft transplantation (L-CAT) without MMC and Group B (20 eyes) operated with injection of 0.1 mL of MMC 0.15 mg/mL 1 month before L-CAT surgery. Exclusion criteria included patients with symblepharon, cicatricial conjunctival diseases, limbal stem cell deficiency, and other intraocular diseases.
Results: A total of four cases of recurrences for Group A (P = 0.012) and one case of recurrence for Group B (P < 0.001) were recorded.
Conclusions: Preoperative injection of MMC in low dose and concentration improves the results of L-CAT in recurrent pterygium.

Keywords: recurrent pterygium, limbal autograft, conjunctival autograft, mitomycin C


Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter

 

Other articles by Dr Mohamed Fakhry


Readers of this article also read: